Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | ABT-751 + Fenretinide |
| Synonyms | |
| Therapy Description | |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| ABT-751 | E7010 | Antimicrotubule Agent 14 | ABT-751 is an anti-mitotic agent that binds to tubulin and exhibits anti-cancer activity in preclinical models (PMID: 19398903, PMID: 23670235, PMID: 30367486). | |
| Fenretinide | 4-HPR|McN-R-1967|fenretinimide | Fenretinide is a retinol analog that binds and activates retinoic acid receptors, potentially resulting in increased tumor cell apoptosis (PMID: 32497314). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|